## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no full-text methods, figures, or statistical details were available for verification
- **Shared manuscript claim summary** The authors report that developmental exposure of male mice to methyl ester sulfonate (MES) via drinking water (0.06, 0.6, and 6 mg/L, from GD 8.5 to PND 56) causes testicular histopathology, reduced serum testosterone, and impaired spermatogenesis. They propose a mechanism whereby MES directly binds and stabilizes GATA2 in Leydig cells, activating TGF-beta1/SMAD signaling, suppressing LHR expression, and thereby impairing testosterone synthesis.
- **Visible evidence base** Abstract text only; no figures, tables, methods, or supplementary materials were provided
- **Missing materials affecting confidence** Full methods, all figures and tables, statistical analyses, dose-response data, raw RNA sequencing results, docking scores, CETSA-WB data, histopathology images, hormone assay details, and any control or validation experiments

## Reviewer
- **Overall assessment** The abstract presents a potentially important finding regarding the reproductive toxicity of a widely used surfactant, with a proposed novel mechanistic axis. However, the evidence base available for review is limited to the abstract, and several critical claims cannot be evaluated without access to the underlying data. The mechanistic model, while coherent, rests on a series of correlative and in silico/in vitro findings that require rigorous validation. The study addresses a relevant environmental health question, but the strength of the conclusions cannot be fully assessed from the supplied material.
- **Who would be interested in the results, and why** Researchers in reproductive toxicology, endocrine disruption, environmental health, and regulatory toxicology would be interested. The findings challenge the safety profile of a "green" surfactant and propose a new molecular axis, which could inform risk assessment and regulatory decisions. The mechanistic focus on GATA2 and TGF-beta1/SMAD signaling may also attract cell biologists studying steroidogenesis.
- **Major strengths** The study addresses a relevant and understudied chemical with broad commercial use. The use of a developmental exposure model is appropriate for assessing reproductive toxicity. The combination of transcriptomics, molecular docking, and CETSA-WB represents a multi-pronged approach to establish direct target engagement. The proposed mechanism is novel and testable.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
  - R1-M4
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3, R1-M4
- **Assessment against Nature-style criteria** Originality: The proposed GATA2/TGF-beta1/LHR axis is novel and not previously described for MES or related surfactants. Scientific importance: The topic is of high relevance to environmental health and reproductive toxicology, and the findings could have regulatory implications. Interdisciplinary readership: The work bridges toxicology, endocrinology, and molecular biology, and would appeal to a broad audience. Technical soundness: Cannot be fully assessed from the abstract; the multi-method approach is promising, but the lack of detail on controls, replicates, and statistical handling prevents verification. Readability for nonspecialists: The abstract is clearly written and accessible, though some mechanistic terms may require background knowledge.
- **Recommendation posture** Supportive if technical concerns are resolved. The core claims are plausible and important, but the current evidence base is insufficient to establish the mechanistic model without full data review.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** "MES directly bound to and stabilized the transcription factor GATA2"
- **Evidence pointer** Molecular docking and CETSA-WB, location not provided
- **Concern** The claim of direct binding and stabilization of GATA2 by MES is based on molecular docking and CETSA-WB, but the abstract does not provide details on the docking methodology, scoring thresholds, or the CETSA-WB experimental conditions. Without these, it is impossible to assess whether the binding is specific, physiologically relevant, or an artifact of the assay.
- **Why it matters** This is the foundational claim of the proposed mechanism. If direct binding is not robustly demonstrated, the entire downstream signaling cascade and the conclusion of a novel axis are unsupported.
- **Resolution test** Provide full docking parameters, scoring functions, and validation with a positive or negative control. For CETSA-WB, include full Western blot images, thermal shift curves, and replicate data. Ideally, confirm binding with an orthogonal method such as surface plasmon resonance or isothermal titration calorimetry.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Causal inference
- **Claim pointer** "GATA2... activated the TGF-beta1/SMAD signaling pathway. This cascade suppressed LHR expression, ultimately impairing testosterone synthesis."
- **Evidence pointer** RNA sequencing and pathway analysis, location not provided
- **Concern** The abstract states that GATA2 activation leads to TGF-beta1/SMAD signaling and subsequent LHR suppression, but no causal evidence is presented. RNA sequencing can show correlative changes in gene expression, but it cannot establish that GATA2 directly drives TGF-beta1 expression or that SMAD signaling directly represses LHR. The abstract does not mention any loss-of-function or gain-of-function experiments, such as GATA2 knockdown or overexpression, or the use of TGF-beta1 pathway inhibitors.
- **Why it matters** The proposed mechanism is a linear cascade, and each step must be causally validated. Without such experiments, alternative explanations, such as indirect effects or off-target actions of MES, cannot be excluded.
- **Resolution test** Include experiments where GATA2 is knocked down or overexpressed in Leydig cells, and assess the effect on TGF-beta1, SMAD phosphorylation, LHR expression, and testosterone production. Use a TGF-beta1 receptor inhibitor to confirm the role of SMAD signaling in LHR suppression.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Dose-response and exposure relevance
- **Claim pointer** "administering MES (0.06, 0.6, and 6 mg/L) via drinking water from GD 8.5 to PND 56"
- **Evidence pointer** Methods, location not provided
- **Concern** The abstract does not report whether the observed effects were dose-dependent. It is unclear if all three doses produced similar effects or if there was a graded response. Additionally, the relevance of these doses to human or environmental exposure levels is not discussed. The lowest dose (0.06 mg/L) may or may not be environmentally relevant, and this is not addressed.
- **Why it matters** Dose-response relationships are critical for establishing causality and for risk assessment. Without this information, it is impossible to determine whether the effects occur at environmentally relevant concentrations or only at high, potentially unrealistic doses.
- **Resolution test** Report the dose-response data for all endpoints, including histopathology, hormone levels, and gene expression. Provide a comparison of the tested doses to measured environmental concentrations of MES or related surfactants.

- **Concern ID** R1-M4
- **Severity** Major
- **Blocking** Yes
- **Axis** Reproducibility and statistical rigor
- **Claim pointer** "significant histopathological alterations... significantly reduced serum testosterone and impaired spermatogenesis"
- **Evidence pointer** Results, location not provided
- **Concern** The abstract reports significant effects but does not provide any statistical details, such as the number of animals per group, the statistical tests used, or the variance. Without this information, the robustness of the findings cannot be assessed. Additionally, the abstract does not mention whether the investigators were blinded to treatment groups during histopathological evaluation.
- **Why it matters** Statistical rigor and blinding are essential to avoid bias and to ensure that the reported effects are reproducible. The lack of these details undermines confidence in the conclusions.
- **Resolution test** Provide full statistical methods, including sample sizes, tests used, and measures of variance. State whether histopathological assessments were performed blinded. Include effect sizes and confidence intervals where appropriate.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity
- **Affected element** Abstract wording
- **Evidence pointer** Abstract, location not provided
- **Issue** The phrase "challenging its safety profile" is somewhat vague. It is unclear whether the authors mean that MES is unsafe at the tested doses, or that the "green" label is misleading.
- **Required correction** Clarify the statement to specify the intended meaning, for example, "challenging the assumption that MES is without reproductive toxicity."

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Completeness
- **Affected element** Exposure window rationale
- **Evidence pointer** Methods, location not provided
- **Issue** The abstract states that exposure was from GD 8.5 to PND 56, but does not explain why this specific window was chosen. It is unclear whether this covers critical periods of Leydig cell development and maturation.
- **Required correction** Provide a brief rationale for the exposure window, referencing known developmental windows of Leydig cell differentiation and function.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Terminology
- **Affected element** "Leydig cells (LCs)"
- **Evidence pointer** Abstract, location not provided
- **Issue** The abbreviation "LCs" is introduced but not used again in the abstract. This is unnecessary and may confuse readers.
- **Required correction** Either use the abbreviation consistently or remove it and write "Leydig cells" in full.

## Risk / unsupported claims
- The claim that MES "directly bound to and stabilized GATA2" is unsupported without full docking and CETSA-WB data.
- The causal sequence "GATA2 activates TGF-beta1/SMAD, which suppresses LHR" is unsupported without functional experiments.
- The claim that this is "the first mechanistic evidence of MES induced reproductive toxicity in mammals" cannot be verified from the abstract alone, as a literature search was not possible.
- The relevance of the tested doses to real-world exposure is not established.
- The statistical robustness of the reported effects is not assessable from the abstract.